0 CHECKOUT

PRODUCT FILTERS

REGION

76
24
18
16
15

COUNTRY

18
10
5
5
2

CATEGORIES

  • 267
  • 57
  • 44
  • 38
  • 28
  • 22
  • 18
  • 18
  • 17
  • 16
  • 14
  • 13
  • 13
  • 13
  • 12
  • 11
  • 10
  • 10
  • 9
  • 9
  • 8
  • 8
  • 8
  • 8
  • 8
  • 7
  • 7
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 5
  • 5
  • 5
  • 5
  • 4
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL

PRICE

411
467
496
617

PUBLISHED

5
33
98
617

PRODUCT TYPE

410
146
32
10
8
3
2
2
2
1
1

Search for: "Metabolic Syndrome"

Diabetes, Metabolic Syndrome and Cardiovascular Disease

There has been a dramatic increase in the incidence of diabetes worldwide, which has been exacerbated by the growing obesity problem across the globe. Once thought of as primarily a childhood disease...

Published:  January 2016
Price:  From

Metabolic Syndrome-Pipeline Insights, 2016

“ Metabolic Syndrome-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Metabolic Syndrome. The report covers the product profiles...

Published:  March 2016
Price:  From

Metabolic Syndrome - Pipeline Review, H1 2014

Metabolic Syndrome - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Metabolic Syndrome - Pipeline Review, H1 2014’, provides an overview of the Metabolic Syndrome’s therapeutic pipeline. This...

Published:  March 2014
Price:  From

Metabolic Syndrome - Pipeline Review, H2 2013

Metabolic Syndrome - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Metabolic Syndrome - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This...

Published:  September 2013
Price:  From

Metabolic Syndrome - Pipeline Review, H2 2012

Metabolic Syndrome – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Metabolic Syndrome - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This...

Published:  September 2012
Price:  From

Metabolic Syndrome - Pipeline Review, H1 2012

Metabolic Syndrome – Pipeline Review, H1 2012 Summary Global Markets Direct’s, 'Metabolic Syndrome - Pipeline Review, H1 2012', provides an overview of the Metabolic Syndrome therapeutic pipeline....

Published:  March 2012
Price:  From

Nutritional And Therapeutic Interventions For Diabetes and Metabolic Syndrome

Diabetes mellitus affects approximately 20 million people in the US, or nearly 7% of the population. It is expected to increase by 70% within the next 25 years, and numerous epidemiologic studies have...

Published:  March 2012
Price: 

Metabolic Syndrome - Pipeline Review, Q4 2010

Metabolic Syndrome - Pipeline Review, Q4 2010 Summary Global Markets Direct’s, “Metabolic Syndrome    Pipeline Review, Q4 2010”, provides an overview of the Metabolic Syndrome    therapeutic pipeline....

Published:  December 2010
Price:  From

Metabolic Syndrome - Pipeline Review, H2 2011

Metabolic Syndrome - Pipeline Review, H2 2011 Summary Global Markets Direct’s, 'Metabolic Syndrome - Pipeline Review, H2 2011', provides an overview of the Metabolic Syndrome therapeutic pipeline....

Published:  October 2011
Price:  From

Metabolic Syndrome and Neurological Disorders

Metabolic syndrome is a recognized suite of biological risk factors that increase the likelihood of developing long–term health problems including a wide range of neurological disorders. Metabolic Syndrome...

Published:  November 2013
Price: 

Metabolic Syndrome - Pipeline Review, Q1 2011

Metabolic Syndrome - Pipeline Review, Q1 2011 Summary Global Markets Direct’s, 'Metabolic Syndrome - Pipeline Review, Q1 2011', provides an overview of the Metabolic Syndrome therapeutic pipeline....

Published:  March 2011
Price:  From

Metabolic Syndrome and Cardiovascular Disease. 2nd Edition

Trends indicate that the metabolic syndrome will become the leading risk factor for heart disease. Now more than ever you need an all–in–one reference that provides the tools and practical advice you...

Published:  September 2012
Price: 

Therapeutic Strategies for the Metabolic Syndrome

The metabolic syndrome is characterised by the presence in a particular individual of a number of metabolic risk factors that combine to put that patient at an increased risk of coronary artery disease,...

Published:  August 2008
Price:  From

The Metabolic Syndrome: The Road Map from Inflammation to Cardiovascular Disease, ICS 1303. Proceedings of the 9th European Symposium on Metabolism, held in Padua, Italy, between 12 and 14 October 2006. International Congress

This collection of papers represents an edited version of the Proceedings of the 9th European Symposium on Metabolism which was held at the University of Padua (Italy) from October 12-14, 2006. As...

Published:  August 2007
Price: 

Metabolic Syndrome and Psychiatric Illness: Interactions, Pathophysiology, Assessment & Treatment

Metabolic syndrome is a set of risk factors that includes: abdominal obesity, a decreased ability to process glucose (insulin resistance), dyslipidemia (unhealthy lipid levels), and hypertension. Patients...

Published:  December 2007
Price: 

Metabolic Syndrome Pathophysiology. The Role of Essential Fatty Acids

Metabolic Syndrome Pathophysiology: The Role of Essential Fatty Acids Metabolic Syndrome Pathophysiology: The Role of Essential Fatty Acids provides current research exploring the links among insulin,...

Published:  February 2010
Price: 

Tumor Lysis Syndrome Global Clinical Trials Review, H1, 2014

Tumor Lysis Syndrome Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Tumor Lysis Syndrome Global Clinical Trials Review, H1, 2014" provides data on the Tumor Lysis Syndrome...

Published:  May 2014
Price:  From

HIV-Associated Lipodystrophy Syndrome Global Clinical Trials Review, H2, 2015

HIV-Associated Lipodystrophy Syndrome Global Clinical Trials Review, H2, 2015 Summary Our clinical trial report, “HIV-Associated Lipodystrophy Syndrome Global Clinical Trials Review, H2, 2015" provides...

Published:  December 2015
Price:  From

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) Global Clinical Trials Review, H2, 2015

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) Global Clinical Trials Review, H2, 2015 Summary Our clinical trial report, “Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) Global Clinical Trials...

Published:  December 2015
Price:  From

Mucopolysaccharidosis II (MPS II) (Hunter Syndrome) Global Clinical Trials Review, H2, 2014

Mucopolysaccharidosis II (MPS II) (Hunter Syndrome) Global Clinical Trials Review, H2, 2014 Summary Our clinical trial report, “Mucopolysaccharidosis II (MPS II) (Hunter Syndrome) Global Clinical...

Published:  September 2014
Price:  From
Loading Indicator

Our Clients

  • Hexcel Corporation
  • Harrods Ltd.
  • Bayer AG
  • Google, Inc.
  • Boeing Company
  • Harley Davidson Motor Company
  • SwissCom AG